{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:18:17Z","timestamp":1767903497162,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2004,6,25]],"date-time":"2004-06-25T00:00:00Z","timestamp":1088121600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1038\/sj.eye.6701446","type":"journal-article","created":{"date-parts":[[2004,6,25]],"date-time":"2004-06-25T09:17:28Z","timestamp":1088155048000},"page":"1264-1269","source":"Crossref","is-referenced-by-count":26,"title":["Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%\/timolol maleate 0.5% and dorzolamide 2%\/timolol maleate 0.5%"],"prefix":"10.1038","volume":"18","author":[{"given":"A G P","family":"Konstas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V P","family":"Kozobolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Lallos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Christodoulakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J A","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W C","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,6,25]]},"reference":[{"issue":"Suppl","key":"BF6701446_CR1","first-page":"S754","volume":"41","author":"N Pfeiffer","year":"2001","unstructured":"Pfeiffer N . A comparison of the fixed combination of latanoprost and timolol with IST individual components in patients with glaucoma or ocular hypertension. The German Latanoprost Fixed Combination Study Group. Invest Ophthalmol Vis Sci 2001; 41(Suppl): S754.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"BF6701446_CR2","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/archopht.120.7.915","volume":"120","author":"EJ Higginbotham","year":"2002","unstructured":"Higginbotham EJ, Feldman R, Stiles M, Dubiner H . Latanoprost and timolol combination therapy vs monotherapy: 1-year randomized trial. Arch Ophthalmol 2002; 120(7): 915\u2013922.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"BF6701446_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1034\/j.1600-0420.2003.00065.x","volume":"81","author":"WC Stewart","year":"2003","unstructured":"Stewart WC, Stewart JA, Day DG, Sharpe ED . Efficacy and safety of timolol maleate\/latanoprost fixed combination vs timolol maleate and brimonidine given twice daily. Acta Ophthalmol Scand 2003; 81(3): 242\u2013246.","journal-title":"Acta Ophthalmol Scand"},{"key":"BF6701446_CR4","first-page":"117","volume-title":"Essentials of Statistics","author":"SA Book","year":"1978","unstructured":"Book SA . Essentials of Statistics. McGraw Hill Book Company: New York, 1978, pp 117\u2013122, 205-215."},{"issue":"8","key":"BF6701446_CR5","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1001\/archopht.1997.01100160145002","volume":"115","author":"AGP Konstas","year":"1997","unstructured":"Konstas AGP, Mantziris DA, Cate EA, Stewart WC . Effect of timolol on the diurnal intraocular pressure in exfoliation and primary open-angle glaucoma. Arch Ophthalmol 1997; 115(8): 975\u2013979.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"BF6701446_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1001\/archopht.1997.01100150184006","volume":"115","author":"AGP Konstas","year":"1997","unstructured":"Konstas AGP, Mantziris DA, Stewart WC . Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol 1997; 115(2): 182\u2013185.","journal-title":"Arch Ophthalmol"},{"key":"BF6701446_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1034\/j.1600-0420.80.s236.34.x","volume":"236","author":"N Orzalesi","year":"2002","unstructured":"Orzalesi N, Rossetti I, Bottoli A, Invernizzi T, Fumagalli E, Fogagnolo P . Comparison of latanoprost, brimonidine and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with primary open-angle glaucoma and ocular hypertension. Acta Ophthalmol Scand Suppl 2002; 236: 55.","journal-title":"Acta Ophthalmol Scand Suppl"},{"issue":"5","key":"BF6701446_CR8","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1755-3768.1987.tb07052.x","volume":"65","author":"GR Duff","year":"1987","unstructured":"Duff GR . A double-masked crossover study comparing the effects of carteolol 1 and 2% on intra-ocular pressure. Acta Ophthalmol (Copenh) 1987; 65(5): 618\u2013621.","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"Part 1","key":"BF6701446_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/eye.2001.14","volume":"154","author":"AG Konstas","year":"2001","unstructured":"Konstas AG, Lake S, Maltezos AC, Holmes KT, Stewart WC . Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine as third-line therapy in exfoliation glaucoma. Eye 2001; 154(Part 1): 59\u201362.","journal-title":"Eye"},{"key":"BF6701446_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1089\/jop.1998.14.129","volume":"14","author":"TK Mundorf","year":"1998","unstructured":"Mundorf TK, Cate EA, Sine CS, Otero DW, Stewart JA, Stewart WC . The safety and efficacy of switching timolol maleate 0.5% solution to timolol hemihydrate 0.5% solution given twice daily. J Ocular Pharmacol Ther 1998; 14: 129\u2013135.","journal-title":"J Ocular Pharmacol Ther"},{"issue":"5","key":"BF6701446_CR11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0002-9394(00)00902-8","volume":"131","author":"WC Stewart","year":"2001","unstructured":"Stewart WC, Day DG, Stewart JA, Schuhr J, Latham KE . The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension. Am J Ophthalmol 2001; 131(5): 631\u2013635.","journal-title":"Am J Ophthalmol"},{"key":"BF6701446_CR12","first-page":"63","volume-title":"Nonparametric Statistics for the Behavioral Sciences","author":"S Siegel","year":"1956","unstructured":"Siegel S . Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill Book Company: New York, 1956, pp 63\u201367."},{"key":"BF6701446_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/00055735-199904000-00004","volume":"10","author":"WC Stewart","year":"1999","unstructured":"Stewart WC . Perspectives in the medical treatment of glaucoma. Curr Opin Ophthalmol 1999; 10: 99\u2013108.","journal-title":"Curr Opin Ophthalmol"},{"issue":"12 Suppl","key":"BF6701446_CR14","first-page":"17","volume":"106","author":"CM Clineschmidt","year":"1999","unstructured":"Clineschmidt CM, Williams RD, Snyder E, Adamsons IA . A randomized trial in patients inadequately controlled on timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Ophthalmology 1999; 106(12 Suppl): 17\u201324.","journal-title":"Ophthalmology"},{"issue":"11","key":"BF6701446_CR15","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1136\/bjo.82.11.1249","volume":"82","author":"J Hutzelmann","year":"1998","unstructured":"Hutzelmann J, Owens S, Shedden A, Adamsons I, Vargas E . Comparison of the safety and efficacy of the fixed combination of dorzolamide\/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study. International Clinical Equivalence Study Group. Br J Ophthalmol 1998; 82(11): 1249\u20131253.","journal-title":"Br J Ophthalmol"},{"issue":"12 Suppl","key":"BF6701446_CR16","first-page":"10","volume":"106","author":"JE Boyle","year":"1999","unstructured":"Boyle JE, Ghosh K, Gieser DK, Adamsons IA . A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol or dorzolamide. Ophthalmology 1999; 106(12 Suppl): 10\u201316.","journal-title":"Ophthalmology"},{"key":"BF6701446_CR17","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0161-6420(03)00404-4","volume":"110","author":"AGP Konstas","year":"2003","unstructured":"Konstas AGP, Papapanos P, Tersis I, Houliara D, Stewart WC . 24-hour diurnal curve comparison of commercially available latanoprost 0.005% vs timolol\/dorzolamide fixed combination. Ophthalmology 2003; 110: 1357\u20131360.","journal-title":"Ophthalmology"},{"issue":"12","key":"BF6701446_CR18","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","volume":"102","author":"A Alm","year":"1995","unstructured":"Alm A, Stjernschantz J . Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning: a comparison with timolol. Scandinavian Latanoprost Study Group. Ophthalmology 1995; 102(12): 1743\u20131752.","journal-title":"Ophthalmology"},{"issue":"1","key":"BF6701446_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","volume":"103","author":"CB Camras","year":"1996","unstructured":"Camras CB . Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a 6-month masked, multicenter trial in the United States. The United States Latanoprost Study Group. Ophthalmology 1996; 103(1): 138\u2013147.","journal-title":"Ophthalmology"},{"issue":"1","key":"BF6701446_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0161-6420(96)30750-1","volume":"103","author":"P Watson","year":"1996","unstructured":"Watson P, Stjernschantz J . A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group. Ophthalmology 1996; 103(1): 126\u2013137.","journal-title":"Ophthalmology"},{"issue":"6","key":"BF6701446_CR21","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0002-9394(02)01460-5","volume":"133","author":"AG Konstas","year":"2002","unstructured":"Konstas AG, Nakos E, Tersis I, Lallos NA, Leech JN, Stewart WC . A comparison of once-daily morning vs evening dosing of concomitant latanoprost\/timolol. Am J Ophthalmol 2002; 133(6): 753\u2013757.","journal-title":"Am J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6701446.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701446","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701446.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:16:51Z","timestamp":1684412211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6701446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,25]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["BF6701446"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6701446","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,25]]}}}